ClinicalTrials.gg
Status unknownNCT03056586pfgpUpdated Mar 7, 2017

The Effect of Pessary Post Vaginal Prolapse Repair, for One Month, to Reduce the Recurrence Rate of Prolapse

An interventional study of vaginal pessary in Use of Pessary Reduce the Number of Prolapse Recurrence, Uterine Prolapse and Cystocele, sponsored by Meir Medical Center. Status unknown. Open to female participants aged 30 Years to 80 Years. Per ClinicalTrials.gov, last updated 2017-03-07.

Sponsored by Meir Medical Center · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Mar 2017), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Non-randomized
Ages
30 Years to 80 Years
Sex
Female
01

Study summary

Genital prolapse is a common complain. 30-40% of women will complain of uterine prolapse or cystocele or rectocele, or mixed. About half of them will require surgical repair for the prolapse, with or without hysterectomy. Of these patients about 30-40% will have recurrence of the prolapse, which in some cases requires second operation.

In this study the investigators want to investigate whether a vaginal pessary inserting in the end of the primary surgery, for 4 weeks, will reduce the recurrence rate.

Read the detailed description

All patients going for vaginal surgery for genital prolapse, stage 3-4, with cystocele, rectocele or uterine cervix prominent from the vagina. These patients, after signing an informed consent, a vaginal pessary will insert at the end of the operation and will stay for 4 weeks post-op.

After 4 weeks the pessary will be removed, and the patient will followed for 2 years, for recurrence of prolapse.

02

Conditions studied

  • Use of Pessary Reduce the Number of Prolapse Recurrence
  • Uterine Prolapse
  • Cystocele
  • Rectocele
03

In context

Uterine Prolapse

111 studies on the registry are indexed under Uterine Prolapse; 18 are open to participants now.

This study's planned enrollment of 100 is above the median of 70 across 76 interventional studies indexed under Uterine Prolapse.

Browse Uterine Prolapse studies →

Lead sponsor

Meir Medical Center is the lead sponsor of 401 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 80 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • all healthy patients with genital prolapse grade 3-4, going for vaginal surgery
  • age 30-80years

Exclusion criteria

Exclusion Criteria:

  • patients with pelvic inflammatory disease
  • patients after pelvic irradiation
  • large vaginal erosion
  • vaginal bleeding uncontrolled or undiagnosed
  • patients going for surgery with mesh
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    1. study group

    100 patients who agree to participate in the study, will be operate according to our protocol for pelvic organ prolapse. At the end of the operation a vaginal pessary will be inserted and suture to the vaginal walls for a 4 week period. Follow-up will be after 3, 6, and 12 month period.

    Device: vaginal pessary

  • No intervention
    2. control

    100 Women who will refuse to participate in the study, will agree to be follow-up by our team for 3, 6, and 12 month post operative.

Interventions

  • Devicevaginal pessary

    A vaginal pessary will be inserted at the end of the operation, for genital prolapse, and will be sutured to the vaginal wall. The pessary will stay in the vagina for 4 weeks.

06

What researchers measure

Primary outcomes

  1. Reduction of recurrence rate of vaginal prolapse, post vaginal surgery repair.

    The investigators hope to see a low percentage of prolapse recurrence in the study (pessary) group, comparing to the control (no pessary) group

    Time frame: 24 month

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 7, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03056586
Responsible party
Klein zvi (Head of urogynecology unit, Meir Medical Center) — Principal investigator
First posted
Feb 17, 2017
Start date
Mar 20, 2017 (estimated)
Primary completion
Dec 20, 2018 (estimated)
Completion
Dec 20, 2019 (estimated)
Last update
Mar 7, 2017

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion